News

Proteomics International Laboratories (ASX:PIQ) contracts Biotem to manufacture test kits – The Market Herald

The company, Biotem, has been contracted to manufacture test kits for the PromarkerD predictive test for diabetic kidney disease, using a ‘fingerprint’ of protein biomarkers in the blood.

The test can predict future kidney function decline in patients with type 2 diabetes and no existing diabetic kidney disease using a simple blood test.

Article: Proteomics International Laboratories (ASX:PIQ) contracts Biotem to manufacture test kits

Subscribe
  • This field is for validation purposes and should be left unchanged.